Hanmi Pharmaceuticals established its subsidiary Beijing Hanmi in 1996 and this has been recognized as the most successful case of glocalization among Korean pharmaceutical companies entering the Chinese market. Beijing Hanmi, equipped with a Research & Development Center, GMP plant and nation-wide sales force in China, has been demonstrating dramatic top-line growth, posting over 20% CAGR in recent years.
The company markets over 20 products in a variety of treatment areas at present. Major products currently generating sizeable sales include Mami Ai (pediatric digestive supplement with lactic acid bacteria), Etanjing (cough medicine), and Mechanang (gastrointestinal treatment). In addition, Beijing Hanmi Research Center is working on a number of collaborative R&D projects with Hanmi Research Center in Korea in order to accelerate the launch of new products in the global market.
- Address
- 10 Tianzhu West Road, Tianzhu Airport Industrial Zone A, Shunyi District, Beijing,China (101312)
- Tel No
- 86-10-6464-3435
- Fax No
- 86-02-6464-3406
- URL
- www.bjhanmi.com.cn